- CNW Group•2 days ago
Oncolytics Biotech® Inc. Announces Details of 2017 Annual Meeting of Shareholders
- PR Newswire•2 days ago
CALGARY, April 27, 2017 /PRNewswire/ - Oncolytics Biotech® Inc. (Oncolytics or the Company) (ONC.TO) (ONCYF) announced today that its 2017 Annual Meeting of Shareholders will be held on Thursday, May 4th, 2017 at 4:00 pm ET (2:00 pm MT) at the Toronto Region Board of Trade located at First Canadian Place, Suite 350, 77 Adelaide Street West, Toronto, Ontario. Following the business portion of the meeting, Dr. Matt Coffey, President and CEO of Oncolytics, will discuss recent progress in the development of REOLYSIN®, including recent randomized phase 2 metastatic breast cancer results as well as the detailed clinical development plan and specific initial registration pathway for REOLYSIN. A live audio webcast of Dr. Coffey's presentation will begin at approximately 4:15 pm ET (2:15 pm MT) and be available at http://event.on24.com/r.htm?e=1415093&s=1&k=1D9EC98BC2D829CD19D1A85F7769DEAC and on the company's website at http://www.oncolyticsbiotech.com/investor-centre/presentations.
- Accesswire•3 days ago
Research Reports Initiated on Healthcare Stocks: Cardiome Pharma, Immunovaccine, Oncolytics Biotech, and Aeterna Zentaris
LONDON, UK / ACCESSWIRE / April 26, 2017 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected ...
ONC.TO : Summary for ONCOLYTICS BIO - Yahoo Finance
Oncolytics Biotech Inc. (ONC.TO)
Toronto - Toronto Delayed Price. Currency in CAD
Add to watchlist
|Day's Range||0.77 - 0.87|
|52 Week Range||0.19 - 1.13|
|PE Ratio (TTM)||-6.27|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|